Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACRX

AcelRx Pharmaceuticals (ACRX) Stock Price, News & Analysis

AcelRx Pharmaceuticals logo

About AcelRx Pharmaceuticals Stock (NASDAQ:ACRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.49
$0.86
52-Week Range
N/A
Volume
243,500 shs
Average Volume
137,683 shs
Market Capitalization
$14.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AcelRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACRX Stock News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

ACRX Stock Analysis - Frequently Asked Questions

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) released its earnings results on Monday, November, 15th. The specialty pharmaceutical company reported ($1.40) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($1.40). The specialty pharmaceutical company earned $1.86 million during the quarter, compared to analysts' expectations of $1.20 million.

Shares of AcelRx Pharmaceuticals reverse split before market open on Wednesday, October 26th 2022.The 1-20 reverse split was announced on Wednesday, October 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AcelRx Pharmaceuticals investors own include Advanced Micro Devices (AMD), Novavax (NVAX), Amarin (AMRN), Amicus Therapeutics (FOLD), Inovio Pharmaceuticals (INO), Meta Platforms (META) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/15/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ACRX
CIK
1427925
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$47.76 million
Net Margins
N/A
Pretax Margin
-3,711.25%
Return on Equity
-81.54%
Return on Assets
-46.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.04
Quick Ratio
4.04

Sales & Book Value

Annual Sales
$1.77 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.65 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
16,950,000
Free Float
16,443,000
Market Cap
$14.58 million
Optionable
Optionable
Beta
0.52

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ACRX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners